ArticleFrontiers in pharmacology2022

Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China.

Hong-Shuai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.